Momtaz Abdelwahab, Egypt
Faculty of medicine, Kasr Alainy, Cairo University Psychiatry and addiction medicineAuthor Of 1 Presentation
An examination of motives for tramadol and heroin use in an Egyptian sample - EPV0061
Abstract
Introduction
introductin:Tramadol misuse is a significant problem in Egypt, yet little is known about tramadol users.
Objectives
objective: to examine the motivations for use of tramadol or heroin among
patients in substance use disorder treatment in order to understand their unique treatment
profiles.
Methods
A cross-sectional observational study was conducted with 100 treatment-seeking
men who reported either tramadol or heroin as their primary substance. Patients were
recruited in 2014–2015 from inpatient and outpatient addiction treatment units in a public
and private hospital in Cairo. A clinical assessment examined their motives for initiation and
continuation of use of either substance based using the following categories: Negative
reinforcement (Pain Avoidance), Positive reinforcement (Pleasure Seeking), Incentive salience
(Craving), Stimulus-response learning (Habits), Impaired inhibitory control (Impulsivity), and
Quasi-medical. Bivariate comparisons of mean scores on motive items and aggregate categories
were conducted for tramadol vs. heroin groups; multivariate regression analyses
controlled for demographic covariates and treatment site.
Results
A majority of the sample
endorsed multiple motives for initiation and continuation of use of their primary substance.
Primary heroin users were more likely to initiate use due to pain avoidance, whereas
primary tramadol users were more likely to initiate use for pleasure seeking (p¼0.002). Pain
avoidance was the strongest motive category for continuation of use for both groups.
Craving was a stronger motivation for initiation and continuation of use among heroin
patients.
Conclusions
Patients in treatment for primary use of tramadol or heroin display unique profiles
of motivations for initiation and continuation of use, which should be considered within
treatment interventions.